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Abstract: Human blood cells may offer a minimally invasive strategy to study systemic alterations of
mitochondrial function. Here we tested the reliability of a protocol designed to study mitochondrial
respiratory control in human platelets (PLTs) in field studies, using high-resolution respirometry
(HRR). Several factors may trigger PLT aggregation during the assay, altering the homogeneity of the
cell suspension and distorting the number of cells added to the two chambers (A, B) of the Oroboros
Oxygraph-2k (O2k). Thus, inter-chamber variability (∆ab) was calculated by normalizing oxygen
consumption to chamber volume (JO2) or to a specific respiratory control state (flux control ratio, FCR)
as a reliable parameter of experimental quality. The method’s reliability was tested by comparing
the ∆ab of laboratory-performed experiments (LAB, N = 9) to those of an ultramarathon field study
(three sampling time-points: before competition (PRE, N = 7), immediately after (POST, N = 10)
and 24 h after competition (REC; N = 10)). Our results show that ∆ab JO2 changed PRE-POST, but
also for LAB-POST and LAB-REC, while all ∆ab FCR remained unchanged. Thus, we conclude that
our method is reliable for assessing PLT mitochondrial function in LAB and field studies and after
systemic stress conditions.
Keywords: platelets; respirometry; field study; physical exercise; quality control; mitochondrial function
1. Introduction
Investigating changes of mitochondrial function improves our understanding of the
physiology and pathophysiology of various diseases [1,2], aging [3], obesity [4], or ac-
climatization to physical activity as opposed to a sedentary lifestyle [5,6]. High-Resolution
Respirometry (HRR) or High-Resolution FluoRespirometry (HRFR) is widely used for anal-
ysis of mitochondrial oxidative phosphorylation (OXPHOS), using different sample prepa-
rations of intact or permeabilized cells, permeabilized muscle fibres, isolated mitochondria,
and tissue homogenates [1,2]. Various combinations of mitochondrial coupling control
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states and electron transfer pathways can be investigated using Substrate-Uncoupler-
Inhibitor-Titration (SUIT) protocols [1,2,7].
Changes in mitochondrial function in response to different exercise training interven-
tions have been assessed in either isolated mitochondria or permeabilized muscle fibres
obtained from vastus lateralis muscle biopsies [8]. However, results may vary depending
on the SUIT protocol or tissue as well as the method of tissue preparation [1,2], the type
of muscle and its fiber-type composition [9,10], the sampling depth [7] and mitochondrial
subpopulations studied [9]. Human blood cells may offer a minimally invasive strategy to
study the systemic alterations of mitochondrial function [1,11–15]. In primates and older
adults, blood cell bioenergetic changes are associated with skeletal muscle and cardiac
mitochondrial alterations [12,13].
Usually, HRR or HRFR are performed in a laboratory under controlled conditions.
However, when studying e.g., physiological responses following endurance competitions,
on-site setups are necessary to avoid prolonged sample transport, which could affect
experimental results [11]. Time constrains due to multiple participants finishing within
a short time period require fast and efficient collection, processing and analyses of the
samples while still maintaining highest standards.
Both peripheral blood mononuclear cells (PBMCs) and PLTs are easily obtainable and
suitable for HRR. Although purification procedures of both blood cell subpopulations
from whole blood are similar, PLTs preparations are easier as they require less blood
and fewer centrifugation steps [11]. In comparison, sample preparation for PBMCs takes
about one hour, which is comparable to permeabilized muscle fibre preparations, while
only 40 min are needed for PLT preparations [16]. Furthermore, PBMCs are composed
of heterogeneous subpopulations of cells including monocytes, lymphocytes (T- and B-
cells, natural killer cells), and dendritic cells [11,15]. These different cell types often exhibit
specific respirometric profiles that are potentially differently affected by exercise [15]. As
systemic stress such as prolonged exercise induces shifts within individual subgroups
of PBMCs (decrease of lymphocyte but increase of monocyte populations) [17], potential
changes in PBMC respiration following exercise could reflect either the change in the
composition of PBMC subpopulations or changes in mitochondrial function.
Hence, metabolically highly active but homogenous PLTs might be a valuable surro-
gate to investigate systemic changes of mitochondrial function, since they are involved
in a variety of systemic reactions (e.g., hemostasis, immunoregulation, inflammation or
oxidative stress) [18–20]. Assessing PLT bioenergetics as a systemic marker has been per-
formed in the context of various diseases [15,19,21–28] as well as training studies [29–33].
However, changes in PLT bioenergetics after an ultramarathon competition in the context
of a field study has not been assessed so far.
Thus, we developed a simple and fast method for PLT isolation from blood samples
and on-site analysis of mitochondrial function. The aim of this work was to assess methods’
reliability derived from a parameter of experimental quality obtained during field and
laboratory experiments. Subsequently, we provide a detailed description of required
materials, experimental procedures and workflow of sample preparation.
2. Materials and Methods: A Guideline for HRR in PLTs
This experimental approach was developed for an ultramarathon field study involving
10 male ultramarathon runners. PLT mitochondrial respiration was measured at 3 time-points:
~12 h before the start of the competition (PRE), within 10 min (POST) and 24 h (REC) after
finishing the race. We evaluated our method by comparing flux control rations (FCR), a reliable
parameter of experimental quality, obtained from field and laboratory experiments.
2.1. Sampling and Cell Purification
Our separation procedure offers a fast way to obtain a sufficient cell number suitable
for HRR. Instead of using three consecutive centrifugation steps for PLTs purification, we
use only two with the first centrifugation step being performed at slightly higher g, to
Cells 2021, 10, 2088 3 of 19
ensure sedimentation of cells with higher mass, thus improving sample purity. Despite
the higher loss of PLTs during this step, the Oroboros O2k is sensitive enough to obtain
valid results from a limited number of cells recovered using our protocol [11,34]. Required
materials and chemicals for sampling, purification, and performing SUIT protocols are
given in Tables 1–3.
Table 1. Materials for blood sampling, O2k sample preparation, and subsample storage.
Materials for Blood Sampling Provider
1 9 mL VACUETTE
® K3EDTA tubes and 21-gauge butterfly
needles (2 per participant)
Greiner Bio-One,
Kremsmünster, Austria
2 Set of automatic pipettes and tips (1 × 2.5 mL, 1 × 1 mL, 1 ×2 µL)
3 Respiratory medium (MiR05)
1 (minimum 4.5 mL for each
experiment; SUIT, background exp., O2 calib.)
Oroboros Instruments,
Innsbruck, Austria
4 Centrifuge with a swinging bucket rotor and slots for 50 mLand 15 mL tubes and 9 mL vials; min. 1000× g available
Hettich Rotina 35,
Tuttlingen, Germany
5 Eppendorf centrifuge with slots for 1.5 mL tubes; min. 1000×g available
Eppendorf AG, Hamburg,
Germany
6 Eppendorf tubes, 1.5 mL (2 tubes for each SUIT experiment) Eppendorf AG, Hamburg,Germany
7 Thermometer




9 Polystyrene box with dry ice, protected from light
10 PBS (1 mL for each experiment) BE 17-516F, Lonza
11 Automated Cell counter See discussion
1 Additional respiration medium is needed for diluting cell concentrations to 200 × 106 cells per mL and for
storing subsamples for measurement of additional parameters (see Table 4).
Table 2. Materials for O2k FluoRespirometry (HRFR).
Materials for Respirometry Provider
1
O2k for high-resolution Fluo-respirometry including
Titration-Injection micropump (TIP), ISS-Integrated Suction
System (ISS) (6 instruments)
Oroboros Instruments,
Innsbruck, Austria
2 Aqua distilled; 70% Ethanol; 100% Ethanol
3 Respiratory medium (MiR05) (4.5 mL for both each O2calibration and instrumental O2 background exp.)
Oroboros Instruments,
Innsbruck, Austria
4 Chemicals for O2k assay (see Table 4)
5
O2k titration sets (6 × 10 µL, 6 × 25 µL, 1 × 50 µL, 1 × 100
µL, 1 × 500 µL; Hamilton Syringes) (number according to
number of simultaneous working researchers)
Oroboros Instruments,
Innsbruck, Austria
6 O2k-Fluo LED2-Module (6 modules) 1
Oroboros Instruments,
Innsbruck, Austria
7 O2k titration set (3 × 10 µL; Hamilton syringes) (numberaccording to number of simultaneous working researchers)
Oroboros Instruments,
Innsbruck, Austria
8 Chemicals for fluorometry (see Table 4)
1 At least 6 instruments are recommended for a study design used in Hoppel et al (2021) [18].
For this protocol, the time required for sampling and PLT purification and transfer
of platelets into the O2k chambers is 40 min (Table 4). Based on our experience, PLT
purification is recommended to be performed as quickly as possible without changing
environmental temperature, since PLTs are very sensitive to these factors and could be
activated to form aggregates.
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Table 3. Chemicals and SUIT-protocol for O2k FluoRespirometry with LED-2-modules based on the






SUIT protocol for HRR
ce1 Sample
ce1P Pyruvate 2 M 5 µL 5 mM
ce2M Malate 400 mM 10 µL 2 mM
1Dig Digitonin 50 mg/mL 8 µL 200 µg/mL
2D Adenosinediphosphate 500 mM 4 µL 1 mM
3G Glutamate 2 M 5 µL 5 mM






1 nM 1 µL/step 0.5 µM steps
6Rot Rotenone 1 mM 4 µL 2 µM
7Ama Antimycin A 5 mM 0.5 µL 1.25 µM
Optional SUIT protocol for Fluorometry
ce1AmR AmplexUltraRed 10 mM 1 µL 5 µM
ce2HRP HorseradishPeroxidase 500 U/mL 4 µL 1 U/mL
ce3SOD SuperoxideDismutase 5000 U/mL 1 µL 2.5 U/mL
perform SUIT protocol for respirometry 2
ce4H2O2
Hydrogen
Peroxide 40 µM 5 µL 0.1 µM
ce5H2O2
Hydrogen
Peroxide 40 µM 5 µL 0.1 µM
Additional chemicals are required: Mitochondrial respiration medium MiR05 according to Fasching, et al [35]
containing EGTA (0.5 mM), MgCl2. 6 H2O (2 mM), Lactobionic Acid (60 mM), Taurine (20 mM), KH2PO4 (10
mM), HEPES (20 mM), D-Sucrose (110 mM), BSA (1 g/L) [22]; Dithionite solution (30 mM) in Phosphate buffer (50
mM, pH 8) for O2 background calibration. 1 Multiple titrations to reach maximum flux of ET capacity (NS(PGM)E);
no uncoupling effect could be observed in our experiments. SUIT-protocol will be discussed according to [1]. 2
SUIT-protocol for respirometry has to be performed after ce3SOD, followed by ce4H2O2.
Egtazic acid (EGTA) can be added to the sample to avoid aggregation [11]. In case of a
delay, PRP can be temporarily stored at 37 ◦C and protected from light (warm bath in a closed
polystyrene box) between the 2 centrifugation steps for up to 10 min. Storing the PRP for longer
may increase the risk of PLT aggregation. In general, we observed O2k experimental flux being
less effected by artefacts after storing PRP for a short time (~5 min) before pelleting the cells
(2nd centrifugation step). Moreover, also storing the purified platelets following resuspension
in mitochondrial respiration medium (MiR05, after the 2nd centrifugation step) should be
avoided, since PLT O2 flux tends to be lower or even deteriorate after storage in MiR05. For all
centrifugation steps, the temperature was set to 23 ◦C.
If a device for cell counting is available, each sample should be measured follow-
ing resuspension in pre-heated (37 ◦C) MiR05 and diluted to a final cell concentration
of 200 × 106 cells per mL by adding MiR05. This concentration has been previously rec-
ommended by Sjövall et al. for maximal O2 flux in human PLTs (see steps 6, 8 and 9 of
Table 4) [34]. At the end of HRR experiments, we recommend recovering subsamples from
the O2k chamber and storing these on dry ice after for subsequent determination of protein
concentration or citrate synthase activity (see step 12 of in Table 4).
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Table 4. Protocol for sample and simultaneous O2k preparation.
Contents of Every Single Step of the Procedure
1. Pre-heat MiR05 before use in a prepared water bath at 37
◦C in a Styrofoam box shielded
from light.
2. Run air calibration of the O2k with MiR05 at 37
◦C including a stirrer test according to
Fasching & Gnaiger, 2018 [36]; keep them running in MiR05 until cells are added.
3. Collect 2 × 9 mL blood in VACUETTE® K3EDTA vials from each participant
5. Centrifuge both 9 mL K3EDTA vials at 400× g at RT for 10 min; set no brake to avoidperturbation of cell layers.
6. Pipette PRP gently until ~1 cm above cell pellet remains, transfer PRP into a 50 mL Falcontube, store regularly for up to 10 min at 37 ◦C protected from light.
7. Centrifuge PRP to collect PLTs and PPP (1000× g, RT, 10 min, acceleration 9, brake 6).
9. Resuspend cell pellet (step 7) by gentle pipetting in 4.5 mL pre-heated MiR05; use 1 mL tips.
10. Determine cell concentration
1 and dilute to 200 × 106 cells per mL cells with preheated
MiR05.
11. Siphon off all MiR05 from the O2k and add 2.25 mL sample to each O2k chamber, close thechambers avoiding air bubbles, and siphon off excess medium from the stopper receptacle.
12. Start data recording with DatLab.
13.
After terminating the respirometric experiment, transfer subsamples of the cells suspension
(1 mL) from the O2k chamber while the stirrer is running, pellet the cells in Eppendorf
tubes (1000× g, RT, 10 min, brake), resuspend in 300 µL PBS, and store on dry ice in
Eppendorf tubes.
1 The preferred instrument is the Sysmex cell counter. See discussion for recent advancements. PRP, platelet rich plasma.
2.2. High-Resolution Respirometry
The Oroboros O2k for High-Resolution FluoRespirometry (Oroboros Instruments,
Innsbruck, Austria) was used to measure sample O2 consumption using two 2-mL Duran
glass chambers under continuous stirring and temperature control at 37 ◦C ± 0.001 ◦C [1].
Since the volume-specific O2 flux at the experimental concentration of PLTs is low, rigorous
corrections for oxygen background flux, two-point oxygen signal calibration, and an
adequate number of data points in each respiratory state are required. Experimental
background flux evaluation is usually performed after every O2k assembly or at regular
intervals, respectively, to exclude instrumental artefacts [35]. Thus, this is an important
part of quality control also in field studies and was performed right after O2k assembly at
the beginning of our project prior to the first experiments. The background settings were
further used for all 3 experimental days of the ultramarathon study. See Table A1 in the
Appendix A for experimental background details.
The polarographic oxygen sensors (POS) were calibrated to ambient air O2 pressure
at physiological temperature (37 ◦C) once every day with MiR05, which is commonly per-
formed in the mitochondrial respiratory medium used for subsequent experiments as rec-
ommended (see Table 3 for details of mitochondrial respiration medium MiR05) [1,35–37].
The respiration media used for calibration was removed from the chambers by aspiration
and the prepared samples were transferred into the O2k chamber. After closing both O2k
chambers, the O2 flux signal (JO2; pmol/s/mL) stabilizes and the oxygen consumption in
the different respiratory states can be recorded. Transitions from a state to another, as well
as specific activation or inhibition of mitochondrial respiratory complexes were obtained
by titration of chemicals according to the SUIT-protocol described below.
2.3. SUIT-Protocol for Platelets
To analyze mitochondrial function in PLTs, we used a modified Oroboros SUIT 8
protocol optimized for permeabilized cells [1]. Saturating, but not inhibiting substrate
concentrations as well as physiological temperature during the experiment are important
quality criteria for optimal O2 flux [37]. Hence, appropriate substrate concentrations were
evaluated prior to the experiments and the experimental temperature was set to 37 ◦C.
The following respiratory states and electron transfer-pathways are characterized
with SUIT-protocols: ROUTINE (R), LEAK (L), OXPHOS (P), ET (E), and ROX. ROUTINE
Cells 2021, 10, 2088 6 of 19
reflects respiration in non-permeabilized cells where respiration is sustained by endogenous
substrates (R) or by pyruvate and malate (R(PM)) sustaining the NADH-pathway (N).
Following plasma membrane permeabilization with the mild detergent digitonin, LEAK
(L) respiration is obtained (N(PM)L). The presence of the reducing substrates pyruvate and
malate (PM) and the subsequent addition of ADP triggers the transition from the LEAK to
the NADH-linked OXPHOS state (P) (N(PM)P, N-pathway in presence of PM and ADP). N-
linked OXPHOS capacity is fully stimulated by addition of glutamate (G) (N(PGM)P). The
synergy with complex II was evaluated following addition of succinate (S), (NS; titration of
S to PGM (NS(PMG)P)), electron transfer-pathway capacity (ET) in non-coupled conditions
is obtained by stepwise titrations of Carbonyl cyanide m-chloro phenyl hydrazine (CCCP)
(NS(PGM)E). Selective inhibition of complex I with rotenone (Rot) allows evaluation of
the contribution of the S-pathway to ET-capacity (S(Rot)E). Residual oxygen consumption
(ROX) was obtained by adding Antimycin A, an inhibitor of complex III.
Volume-specific JO2 can be normalized per cell number (pmol/s/106 cells per mL)
when the cell concentration is known, or per specific amount of marker (protein content
[pmol/s/mg)]) if citrate synthase activity or mitochondrial protein content are evaluated
on subsamples of PLTs (see Table 4 for workflow). FCR are obtained by normalization
of O2 fluxes to a reference state, normally the highest one observed during the SUIT
protocol. Flux control efficiency (jZ-Y) expresses the relative change of respiration in a
defined coupling state in a step, caused by a specific metabolic control variable. Hence,
jZ-Y enables analyses of an O2 flux step, caused by the titration of a single substrate, by
using the next higher flux as reference, while FCR express fluxes relative to a reference
state (Table 5) [2,38]. Results expressed by FCR and jZ-Y are statistically more robust as they
are independent of cell number or external mitochondrial markers [2]. However, they only
express qualitative, and not quantitative mitochondrial respirometric changes [2]. FCR and
jZ-Y investigated using our SUIT-protocol are given in Table 5. Raw data were corrected by
ROX (non-respirometric oxidative side reactions) subtraction prior to calculation of both
FCR and jZ-Y.
Table 5. Respiratory states, flux control ratios, and flux control efficiency, ROX-corrected.
State Flux After Event FCR JZ-Y
ROUTINE R ce1 R
ROUTINE (PM) R(PM) ce2PM PMR
LEAK (L) N(PM)L 1Dig PML
OXPHOS (P) N(PM)P 2D PMP 1-N(PM)L/N(PM)P
OXPHOS (P) N(PGM)P 3G PGMP 1-N(PM)P/N(PGM)P
OXPHOS (P) NS(PGM)P1 4S 1-N(PGM)P/NS(PGM)P
ET (E) NS(PGM)E 5U PGMSE 1-NS(PGM)E/N(PGMS)p
ET S (E) S(Rot)E 6Rot SE 1-S(Rot)E/NS(PGM)P2
ROUTINE (R) respiration of intact cells with endogenous substrates; LEAK (L) in the absence of adenylates; OXPHOS
(P) in the presence of saturating [ADP]; ET (E) after uncoupler titration to obtain maximum flux. 1 NS(PGM)P was
used for normalization for calculating FCR. 2 NS(PGM)P instead of NS(PGM)E was used for normalization.
Usually, E is equal to or greater than P, thus the ratio of E to P after uncoupler titration
is E ≥ P [2]. OXPHOS exceeding ET (E < P) is theoretically impossible but can be caused
e.g. by low O2 concentration in the O2k chambers inhibiting respiration [2]. In some
runs, we observed E < P (<5%), despite sufficient oxygen (see Figures 1 and 2). The
reason for this observation remains unclear but is likely an experimental artefact. For
this reason, we assumed E = P in our experiments [2]. Hence, NS(PGM)P is the more
representative flux state for normalization in calculating all FCR and the JZ-Y for Rotenone
[1-S(ROT)E/NS(PGM)P].
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Figure 1. Representative respirometric trace following SUIT 8 protocol. Blue line: O2 concentration, measured at 2-second
time intervals, showing the decline over time and the effect of oxygen added with titrations (particularly with substances
dissolved in ethanol containing a high concentration of O2; see CCCP and rotenone titrations). Oxygen concentration was
sufficient to maintain cell respiration. Red line: volume-specific O2 flux, calculated as the negative time derivative of O2
concentration, corrected for instrumental background, and expressed as pmol/s/mL. The slope was calculated for each data
point using a non-linear fit over the preceding 25 data points. Titrations cause intermittent disturbances of the slope due to
O2 injections, and these sections were removed. A slight but constant decrease in O2 flux from NS(PGM)P to NS(PGM)E
and S(Rot)E is apparent. For titration steps see Table 3. The representative experiment was performed in LAB conditions.
Abbreviations: ce, presence of the sample (cells); cePM, presence of the sample, pyruvate and malate; N, N-pathway:
NADH electron transfer-pathway state; NS, NS-pathway: CI&CII linked electron transfer-pathway state; S, S-pathway:
succinate-linked (CII-linked) electron transfer-pathway state; ROX, Residual oxygen consumption; R, Routine state; L, Leak
state; P, Oxidative Phosphorylation (OXPHOS); E, Electron transfer pathway (ET); ADP, adenosine di-phosphate.
Reactive oxygen species (ROS) as a by-product of mitochondrial respiration are known
to increase in response to exercise [39]. ROS can be assessed in parallel with respiration in
the O2k by using the optional O2k-Fluorescence LED2-module and addition of Amplex
UltraRed (AmR), Horseradish peroxidase (HRP), and superoxide dismutase (SOD) into
the medium prior to the SUIT-protocol (High-Resolution FluoRespirometry; HRFR) [40].
Since mitochondrial electron transfer complexes I and III are considered the main sources
of ROS and ROS formation is further associated with changes in intrinsic uncoupling
(increased LEAK-respiration), the real-time determination of the amperometric slope in
N(PM)L, N(PGM)P, NS(PGM)P and S(Rot)E is of particular interest [2,40].
When assessing ROS in our experiments, we observed a distinct and abrupt increase
of the amperometric slope (“oxidative burst”) following digitonin titration for permeabi-
lization. Despite a gradual decline of the subsequent signal, possible fluorometric changes
induced by substrate addition were overlapped by this oxidative burst and could therefore
not be evaluated. Hence, it is not recommended to use the LED2-module in this protocol
for human PLTs, since a meaningful analysis of the amperometric slope is not possible in R
state (see Figure 2). Calibration of the raw signal for fluorescence using H2O2 titrations to
obtain the corrected AmR signal has to be performed both before and after the experimen-
tal SUIT protocol by [40]. See Tables 3 and 4 for required materials and titration steps in
addition to those used for HRR if the LED-2 module is also used.
Cells 2021, 10, 2088 8 of 19
Figure 2. Representative fluo-respirometric trace following SUIT 8 protocol. (a): The blue line shows the O2 concentration
[µM] measured at 2-second time intervals, the red line represents the volume-specific O2 flux [pmol/s/mL] as described in
Figure 1. The volume-specific flux shows instability in relation to the experiment of Figure 1, starting at the point of the
first chemical titrations. The decrease in O2 flux from NS(PGM)P to NS(PGM)E is intensified compared to Figure 1. The
time interval between titration of ADP and G was too short to determine N(PM)P. (b): The black line is the amperometric
signal, converted from the raw data of fluorescence to the total concentration of AmR [µM] after calibration with H2O2. The
amperometric signal is characterized by an average increase over time with slight stepwise changes induced by titrations.
The green line represents the calculated H2O2 flux per volume [pmol/s/mL]. The digitonin titration causes a burst in H2O2
release, slowly decreasing over time, but masking possible changes in H2O2 release. The representative experiment was
performed in the laboratory of Oroboros Instruments. Abbreviations: ce, presence of the sample (cells); cePM, presence of
the sample, pyruvate and malate; N, N-pathway: NADH electron transfer-pathway state; NS, NS-pathway: CI&CII linked
electron transfer-pathway state; S, S-pathway: succinate-linked (CII-linked) electron transfer-pathway state; ROX, Residual
oxygen consumption; R, Routine state; L, Leak state; P, Oxidative Phosphorylation (OXPHOS); E, Electron transfer pathway
(ET); ADP, adenosine di-phosphate; AmR, Amplex UltraRed; SOD, Superoxide Dismutase; HRP, Horseradish Peroxidase;
H2O2, Hydrogen Peroxide.
3. Experimental Reproducibility: From Lab to Field
Despite using the same method for blood sampling, cell purification, and experimental
SUIT protocol, the number of confounders is higher field studies compared to laboratory
conditions. Likewise, excessive stress due to exercise-induced PLT activation can also
contribute to PLT aggregation [41]. Cellular aggregation after resuspension of the pellet
(after the 2nd centrifugation step) could worsen reproducibility: if a slightly different
number of cells is added from the same sample to the two O2k chambers, it will result in
different O2 flux rates. This effect might become more apparent when sample preparations
are performed in field conditions or after strenuous exercise. To determine the reliability
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of our method, we compared data obtained from experiments performed both under
standardized laboratory conditions and in the field using identical methods for sampling,
sample preparation and HRR.
3.1. Methods and Study Design
Experimental reproducibility was evaluated by comparing O2k chamber variances of
every experiment, where the sample obtained from each preparation procedure was di-
vided into both O2k chambers (A and B) for HRR. Chamber variances (∆ab) were calculated
by normalizing respiratory chamber differences (A−B) by the respective chamber averages,
∆ab = [(A − B)/AVG(A,B)], for both ROX non-corrected volume-specific O2 flux (JO2) and
FCR. ∆ab as a technical parameter reflects the accuracy of the experimental procedure but
is independent from any mitochondrial respirometric changes. All volume-specific fluxes
(including ROX) and FCR collected by the present SUIT Protocol (Table 5) were included in
the evaluation. During ideal experimental conditions and accurate sample handling, ∆ab is
estimated to be zero at each respiratory state, considering that the two chambers contain
the same number of cells and that the same amount of each compound is added in the two
chambers. Since ∆ab can vary between −2 and +2 (depending on whether O2 flux is A > B
or A < B), we used absolute values of variances for further statistical analyses (|∆ab|).
Significant differences of |∆ab| indicate cellular aggregations at least in one O2k chamber,
thus a qualitative change in PLT sample preparation of experimental performance.
Two groups of participants were included in the evaluation: group 1 was sampled
and assessed in field conditions, whereas for group 2, experiments were performed in
the laboratory of Oroboros Instruments (LAB). Group 1 was composed of 10 participants
of an ultramarathon project (age median: 51.5 years, range: 26–45 years; regular train-
ing/week: 8.5 h, range: 4–15 h), who were sampled three times (PRE-POST-REC) as
described above [18]. Participants of group 2 were 9 recreational endurance athletes (run-
ning, cycling; age median: 31 years, range 29–41 years) who were sampled at least 24 h
after their last training session.
Whole blood was taken from the median cubital vein (9 mL K3 EDTA, BD Vacutainer,
BD diagnostics, New Jersey, United State. |∆ab| calculated for all JO2 and FCR were com-
pared as follows: LAB (N = 9) was compared to all field experiments (LAB-PRE, LAB-POST,
LAB-REC; N = 10) to assess the method’s reliability in less controlled ambient conditions
and the results obtained from the ultramarathon (PRE-POST-REC) were compared to
evaluate the reliability under systemic stress conditions. The data of participants 2, 6,
and 8 in PRE were excluded due to experimental problems (deteriorated experimental O2
flux), which reduced the sample of PRE (N = 7). These data are not shown in graphs and
excluded from statistical analysis. All participants were informed about the procedure and
gave written consent. The study was approved by the local ethics review board (University
of Innsbruck, Institute of Sport Science). The study design and the statistical approach are
shown in Figure 3.
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Figure 3. Study design and statistical approach. PRE, prerace measurements; POST, postrace measurements; REC, recovery
measurements 24 h after individual finish; LAB, experiments performed in the laboratory of Oroboros Instruments.
Repeated measures ANOVA with Bonferroni post-hoc tests was used for PRE-POST-REC comparison, highlighting the
impact of systemic stress on experimental quality. Student’s t-test was used to compare LAB-PRE, LAB-POST, and LAB-REC,
highlighting the impact of changed environmental conditions on experimental quality. |∆ab| of all volume-specific fluxes
(JO2) and FCR were used as parameters. * Experimental data from drop-outs are excluded in the evaluation of biological
adaptations, but are included in the present statistics for experimental quality control.
3.2. Statistics
All ∆ab of JO2 and FCR are shown for every single experiment performed in LAB
conditions (panel a of Figures 4 and 5), PRE (panel b of Figures 4 and 5), POST (panel c of
Figures 4 and 5), and REC (panel d of Figures 4 and 5). To evaluate whether ∆ab is dependent
on the current rate of oxygen consumption averaged for both chambers (JO2), Spearman’s
rank correlation was used (panel f of Figures 4 and 5). To analyze changes LAB-PRE,
LAB-POST, and LAB-REC, the Student’s t-test for unpaired samples was used for normally
distributed data or the Mann-Whitney-U-Test for data not meeting the test requirements.
To analyze PRE-POST-REC changes, a repeated one-way analysis of variance (ANOVA)
with a post-hoc analysis (Bonferroni correction) was used, or the Wilcoxon signed-rank test
and Friedman test. Absolute values of ∆ab were used for the ANOVA, t-test, and Mann-
Whitney-U test (|∆ab|). A p-value below 0.05 was considered as statistically significant.
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Figure 4. Distribution of variances for JO2: The difference of both chambers A and B, divided by the respective chamber
average [∆ab = (A − B)/AVG(A,B)], calculated from ROX non-corrected data. Graphs show ∆ab from experiments performed
in the laboratory of Oroboros Instruments (a) in field conditions before the ultramarathon race (b), right after (c) and 24 h
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after the finish (d). ∆ab for JO2 of all experiments (LAB, PRE, POST, REC) are shown in (e). ∆ab for JO2 are plotted against
average chamber JO2 [pmol/s/mL] to evaluate the dependence of ∆ab on JO2 (f). The linear trend line and a 95% confidence
interval are shown. See Table A1 in the appendix for O2k background correction values and Table A2 for O2 calibration of
each experiment.
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were significantly different, both PRE-POST. All │∆ab│ FCR remained unchanged. ∆ab 
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for ∆ab FCR (r = 0.047, P = 0.464). 
Table 6. Results of │∆ab│ of JO2 and FCR. 
  Field 
 LAB PRE POST REC Adjusted p 
│∆ab│ Volume specific flux    
R 0.099 ± 0.112 0.066 ± 0.103 0.075 ± 0.058 0.095 ± 0.057 0.983 
R(PM) 0.097 ± 0.095  0.064 ± 0.096 0.059 ± 0.058 0.080 ± 0.067 0.983 
N(PM)L 0.149 ± 0.106 * 0.090 ± 0.091 $ 0.057 ± 0.069 0.081 ± 0.072 0.102 
N(PM)P 0.076 ± 0.073 0.068 ± 0.089 0.041 ± 0.043 0.052 ± 0.053 0.204 
N(PGM)P 0.093 ± 0.077  0.045 ± 0.044 0.045 ± 0.049 0.054 ± 0.046 0.135 
NS(PGM)P 0.079 ± 0.079 0.034 ± 0.048 0.036 ± 0.033 0.040 ± 0.048 0.905 
NS(PGM)E 0.080 ± 0.078 0.038 ± 0.044 $ 0.040 ± 0.047 0.043 ± 0.051 0.066 
S(ROT)E 0.083 ± 0.071 # 0.053 ± 0.052 0.059 ± 0.040 0.032 ± 0.034 0.513 
ROX 0.245 ± 0.174 0.311 ± 0.303 0.401 ± 0.429 0.277 ± 0.204 0.565 
│∆ab│ Flux control ratio    
R 0.095 ± 0.084 0.049 ± 0.060 0.079 ± 0.076 0.136 ± 0.078 0.298 
PMR 0.066 ± 0.053 0.038 ± 0.059 0.062 ± 0.075 0.094 ± 0.081 0.479 
PML 0.124 ± 0.101 0.096 ± 0.104 0.066 ± 0.061 0.086 ± 0.068 0.368 
PMP 0.056 ± 0.043 0.050 ± 0.061 0.060 ± 0.034 0.045 ± 0.031 0.565 
PGMP 0.057 ± 0.052 0.021 ± 0.026 0.043 ± 0.039 0.049 ± 0.026 0.576 
PGMSE 0.020 ± 0.015 0.013 ± 0.013 0.026 ± 0.024 0.029 ± 0.022 0.060 
SE 0.019 ± 0.015 0.030 ± 0.038 0.035 ± 0.036 0.029 ± 0.024 0.607 
i re 5. istri ti f ri f r : iffere ce f t c a ers a , i i e b t e respective cha er
average [∆ab = (A − B)/AVG(A,B)]. Raw data were co re ted for ROX and FCR was calculated by normalizing for NS(PGM)P
in every single experiment. Graphs show ∆ab of experiments performed in the laboratory of Oroboros Instruments (a), in
field conditions before the ultramarathon race (b), right after (c), and 24 h after individual finish (d). ∆ab for FCR of all
experiments (LAB, PRE, POST, REC) are shown in (e). ∆ab for FCR is plotted against average chamber JO2 [pmol/s/mL]
to evaluate the dependence of ∆ab of FCR on JO2 (f). The linear trend line and a 95% confidence interval are shown. See
Table A1 in the appendix for O2k background correction values and Table A2 for O2 calibration of each experiment.
3.3. Results
Results are shown in Table 6. Regarding LAB and field experiments, the comparison of
|∆ab| for raw data showed significant changes only for |∆ab|N(PM)L LAB-POST (−62.1%)
and |∆ab|S(ROT)E LAB-REC (−60.0%), and for the comparison of field experiments (PRE,
POST and REC) only |∆ab| N(PM)L (−99.6%) and |∆ab| NS(PGM)E (−99.3%) were
significantly different, both PRE-POST. All |∆ab| FCR remained unchanged. ∆ab was not
correlated to averaged chamber JO2, neither for ∆ab JO2 (r = 0.100, p = 0.095), nor for ∆ab
FCR (r = 0.047, p = 0.464).
Table 6. Results of |∆ab| of JO2 and FCR.
Field
LAB PRE POST REC Adjustedp
|∆ab| Volume specific flux
R 0.099 ± 0.112 0.066 ± 0.103 0.075 ± 0.058 0.095 ± 0.057 0.983
R(PM) 0.097 ± 0.095 0.064 ± 0.096 0.059 ± 0.058 0.080 ± 0.067 0.983
N(PM)L 0.149 ± 0.106 * 0.090 ± 0.091 $ 0.057 ± 0.069 0.081 ± 0.072 0.102
N(PM)P 0.076 ± 0.073 0.068 ± 0.089 0.041 ± 0.043 0.052 ± 0.053 0.204
(PG )P 0.093 ± 0.077 0.045 ± 0.044 0.045 ± 0.049 0.054 ± 0.046 0.135
( )P 0.079 ± .079 0.034 ± 0.048 0.036 ± 0.033 .040 ± 0.048 0.905
E 0.080 ± .078 0.038 ± 0.044 $ 0.040 ± 0.047 .043 ± 0.051 0.066
0.083 0.071 # 0.053 ± 0.052 0.059 ± 0.040 .032 ± 0.034 0.513
0.245 ± 0.174 0.311 ± .303 .401 ± 0.429 0.277 ± .204 0.565
|∆ab| Flux control ratio
R 0.095 ± 0.084 0.049 ± 0.060 0.079 ± 0.076 0.136 ± 0.078 0.298
PMR 0.066 ± 0.053 0.038 ± 0.059 0.062 ± 0.075 0.094 ± 0.081 0.479
PML 0.124 ± 0.101 0.096 ± 0.104 0.066 ± 0.061 0.086 ± 0.068 0.368
PMP 0.056 ± 0.043 0.050 ± 0.061 0.060 ± 0.034 0.045 ± 0.031 0.565
PGMP 0.057 ± 0.052 0.021 ± 0.026 0.043 ± 0.039 0.049 ± 0.026 0.576
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Table 6. Cont.
Field
LAB PRE POST REC Adjustedp
PGMSE 0.020 ± 0.015 0.013 ± 0.013 0.026 ± 0.024 0.029 ± 0.022 0.060
SE 0.019 ± 0.015 0.030 ± 0.038 0.035 ± 0.036 0.029 ± 0.024 0.607
Data are shown as mean ± SD of differences between O2k chambers A and B, normalized by the chamber average
[|(A − B)|/(avg(A,B)] of JO2 and FCR. Adjusted p-values of ANOVA with Bonferroni post-hoc for analysis of
the field experiments (PRE-POST-REC) are given (right column). A t-test for independent samples was used
for LAB-PRE analyses (p-values not shown). * significance between LAB-POST (unpaired t-test); p = 0.05. #
significance between LAB-REC (unpaired t-test); p = 0.05. $ significance between PRE-POST (ANOVA with
post-hoc test); p = 0.05.
4. Discussion
This study evaluated the reliability of a method to assess platelet mitochondrial
function by HRFR in the context of a field study. We compared a technical parameter inde-
pendent of biological changes (∆ab), derived from HRFR experiments acquired during both
laboratory and field conditions. We found slight differences in chamber variability|∆ab|,
but not for derived |∆ab| FCR. The observed difference of raw data does not reflect varia-
tions of experimental quality and was not associated with the level of oxygen consumption
(JO2), but may rather be related to the operator’s level of experience. These findings indicate
that the method is suitable for field studies, since the degree of variability observed in LAB
and field conditions was similar.
Most previous studies using PLTs as a systemic respirometric marker involved dif-
ferent pathologies assessed in laboratory settings [15,21,22,27,28]. Even though de Lucas
et al. used an O2k to assess HRR of human PLTs after ultra-endurance exercise, they did
not evaluate various combinations of mitochondrial coupling control states and electron
transfer pathway states [30]. Moreover, detailed information on the separation process
and the ambient conditions during the experiments were not reported [30]. Previously, we
published an extensive HRFR protocol performed in the context of a field study [18]. Even
though we could not determine distinct race-related changes in mitochondrial function,
the association of PLT respiration with individual race performance, oxidative stress, mus-
cle damage and renal dysfunction indicates the involvement of blood cells in governing
systemic processes [18]. If not, different methods can be used to assess blood-based bioen-
ergetic changes, which are in part complementary, with each having their own strengths
and limitations [15,42].
Assessing chamber variability (∆ab) for both JO2 and FCR allows for testing the relia-
bility of a method and highlights how cellular aggregations may affect O2 consumption in
both chambers. ∆ab is a technical parameter not affected by biological variability, reflecting
quality of sample preparation, precision of titrations and experimental performance. LAB-
to-field study conditions and PRE-POST comparison reveal differences of|∆ab| regarding
JO2 but not for FCR. However, it is expected that PLT aggregation during the experimental
process would affect all mitochondrial respiratory states, resulting in change of ∆ab at
all stages of the experiment. Hence, although several studies reported increased platelet
aggregation in response to exercise [43], we suggest that neither varied experimental condi-
tions (LAB-PRE), nor systemic stress after strenuous workloads (PRE-POST-REC) had an
influence on data reproducibility.
However, differences in chamber variability could possibly be related to the operator’s
experience, such as precision of titrations and/or timing of SUIT protocol injections. Other
specific confounding variables relevant for the assay include the time for O2 flux to stabilize
after digitonin titration. Presumably, the time for JO2 stabilization after full plasma mem-
brane permeabilization, is not identical in both chambers. Hence, estimating the correct
timepoint when JO2 is stable is difficult and depends on the operator’s decision. In general,
the observation of chamber variability in only four tests out of 54 performed cannot be
explained by PLT aggregation in the O2k chambers during the experiment. Additionally,
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|∆ab| of FCR remained unchanged. Considering that FCR, but not ROX non-corrected
JO2 are commonly used for further analysis, these differences are negligible. Overall, the
technical validity and the influence of the operator’s experience on outcomes qualify this
method as reliable for use in-field and laboratory studies.
PLT respiration turned out to be sensitive to prolonged storage of the sample before
O2k experimental analysis. While 5 min of light-protected storage of PRP at physiological
temperature seemed to be the optimum, we found 10 min to be the absolute maximum
for stable O2 flux analysis. When downstream assays are delayed, a good alternative in
field studies is storing the whole blood at both room temperature and 4 ◦C before the
first centrifugation, which did not affect mitochondrial function up to 24 h [34]. However,
in field studies, storage at 4 ◦C may not be possible and storage of up to 24 h may not
be sufficient for transport to a laboratory and further analysis. Hence, any experimental
procedure on-site using a field laboratory has to be planned carefully, avoiding any potential
delays as much as possible. As potential mitochondrial recovery processes after exercise
remain unclear, sampling right after exercise is recommended if the focus lies on acute
adaptations. Hence, a delay in sampling, as well as a delay in sample preparation could
negatively impact results. However, normalized chamber variances of all experiments were
within the same range (−0.4 < ∆ab < 0.4), with a strong trend of LAB experiments being
slightly more variable compared to field experiments (p = 0.05). Alternatively to handling
of PLTs, adding the EGTA-chelating agent can prevent PLTs from forming aggregations [11].
However, an effect of this agent on respirometric outcomes cannot be excluded.
Substrates concentrations yielding maximal O2 flux are a prerequisite to obtain valid
results [1]. HRR experiments performed with too low or too high substrate concentrations
can result in impaired mitochondrial respiration [1]. The same applies to digitonin concen-
trations, which vary in PLTs compared to standard recommendations used for cells (PLTs:
1 µg/106 cells, which is 200 µg/mL for a concentration of 200 × 106 cells per mL) [1,34].
Using an optimal digitonin concentration, the plasma membrane is permeabilized fol-
lowing interaction with its high cholesterol content. Consequently, respiration remains
constant over a defined range of digitonin concentrations by the free exchange of substrates
between the cytosol and the immediate cell environment but tends to decline when the
outer mitochondrial membrane with a low-cholesterol content is affected by an excess of
digitonin [1,2]. The optimal digitonin concentration is commonly tested experimentally
by stepwise titration of low digitonin concentrations (i.e., 10 µg/mL) until the maximal
respiratory response is achieved, confirmed by subsequent outer mitochondrial membrane
integrity test, by adding 10 µM cytochrome c [1,2].
Despite a high digitonin concentration, the final concentration per cell (f.c. 10 µg per
106 cells) is low compared to standard recommendations. The reduced plasma membrane
surface of PLTs, with small diameters of 1–3 µM, would require lower concentrations per
cell, whereas the number of cells present in the chamber is much higher compared to other
cell types [11]. Thus, high final concentrations may contribute to the observed oxidative
burst when using the LED2-Module for fluorometry. In pilot studies, we found that the
outer mitochondrial membrane remained intact, using the cytochrome c test, with a final
digitonin concentration of 200 µg/mL, confirming recommendations of Sjövall et al. [34].
However, recent findings from our working group suggest that a sufficient O2 flux can
be obtained using lower concentrations of digitonin at similar cell concentrations, but by
using an adapted SUIT protocol. Thus, further studies of protocol development can reduce
the risk of using too high digitonin concentrations by stepwise titrations until optimal
O2-flux is reached.
EDTA is recommended as an anticoagulant for PLT respirometry, ensuring the best
experimental results and prevention of platelet activation compared to heparin, citrate,
and acid citrate dextrose [34]. However, we also found sodium citrate to be used in one
study [23]. To our knowledge, it has not been tested explicitly, whether EDTA is the optimal
anticoagulant for PLT respirometry in general or if this is dependent on the SUIT protocol.
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Hence, different anticoagulants should be tested together with different SUIT protocols for
human PLTs.
5. Conclusions
In conclusion, the method presented here was optimized to investigate PLT mitochon-
drial qualitative function in a time- and resource-efficient manner. The method was found
to yield reliable results in both LAB and field conditions, as well as after systemic stress.
Experienced operators and swift performance of all the steps can prevent aggregation
of platelets, which can further improve outcomes. ∆ab is a useful parameter to assess
the reliability of HRR experiments in field and laboratory settings. It reflects both the
homogeneity of the sample and the precision of the operator. In order to exactly identify
and select the phase of O2 flux stabilization after single titration steps, it is necessary to
define a minimum time interval and/or an optimal number of recordings, which requires
a high level of user experience.
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Appendix A
Table A1. O2k background O2 flux in LAB and ultramarathon experiments. Values are shown in
[pmol/s/mL].
O2 Background a◦ O2 Background b◦
O2k Serial
Number A B A B
LAB
G-0003 −2.8046 −2.0394 0.0287 0.0275
G-0006 −2.2446 −2.9382 0.0295 0.0311
G-0064 −2.0428 −1.8178 0.0249 0.0273
G-0008 −2.3598 −2.7908 0.0301 0.0334
G-0006 −2.2446 −2.9382 0.0295 0.0311
F-0050 * −2.0000 −2.0000 0.0250 0.0250
G-0064 −2.4825 −2.0258 0.0305 0.0275
G-0063 −1.6941 −2.2292 0.0273 0.0296
G-0063 −2.4168 −2.4971 0.0327 0.0317
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Table A1. Cont.
O2 Background a◦ O2 Background b◦
O2k Serial
Number A B A B
PRE, POST, REC
G-0002 −2.5226 −3.0570 0.0289 0.0313
G-0006 −2.0208 −1.7848 0.0318 0.0309
G-0008 −2.7778 −2.1008 0.0263 0.0263
G-0062 −2.0303 −1.5078 0.0267 0.0250
G-0063 −1.6941 −2.2292 0.0273 0.0296
G-0064 −2.4825 −2.0258 0.0305 0.0275
O2k background correction for all used O2k in LAB and ultramarathon experiments. Experimental background
for the ultramarathon experiments were performed once on the day before PRE experiments, and used PRE, POST,
and REC. Used LAB experiments were performed in a time range of 2 months, where O2k were disassembled
and repeatedly background-corrected meanwhile. * default background settings were used. O2 background a◦:
Intercept, flux at zero oxygen. O2 background b◦: Slope, flux per oxygen concentration.
Table A2. POS sensor calibration in LAB and ultramarathon experiments.
R1 J◦O2 POS Experiment
O2k Serial
Number A B A B
LAB
G-0003 2.0851 2.2999 2.70 2.95 Exp. 1.1
G-0006 1.9956 2.0786 2.57 2.67 Exp. 1.2
G-0064 1.8829 1.8695 2.45 2.41 Exp. 1.3
G-0008 2.0124 2.1300 2.57 2.74 Exp. 1.4
G-0006 1.9900 2.0883 2.56 2.68 Exp. 1.5
F-0050 2.0575 1.9936 2.65 2.57 Exp. 1.6
G-0064 1.9910 2.0127 2.58 2.59 Exp. 1.7
G-0063 2.1835 1.8911 2.81 2.43 Exp. 1.8
G-0063 2.1778 1.8760 2.79 2.40 Exp. 2.1
PRE
G-0002 1.9937 1.9171 2.57 2.47 Part. 3, 8
G-0006 2.0233 2.0927 2.60 2.69 Part. 7, 10
G-0008 2.0502 1.9348 2.64 2.49 Part. 4
G-0062 2.0845 2.3000 2.70 2.95 Part. 2, 9
G-0063 2.1757 1.9804 2.80 2.54 Part. 1
G-0064 2.0203 2.0680 2.61 2.67 Part. 5,6
POST
G-0002 1.9926 1.9679 2.57 2.53 Part. 3, 8
G-0006 2.0280 2.0724 2.61 2.66 Part. 7
G-0008 2.0410 1.9473 2.62 2.51 Part. 4, 5
G-0062 2.0961 2.3069 2.71 2.96 Part. 2, 9
G-0063 2.2393 1.9716 2.88 2.53 Part. 1
G-0064 2.0203 2.0680 2.61 2.67 Part. 6, 10
REC
G-0002 1.9755 1.9808 2.55 2.55 Part. 3, 8
G-0006 2.0087 2.0628 2.58 2.65 Part. 7, 10
G-0008 2.0339 1.9403 2.61 2.50 Part. 4, 5
G-0062 2.0826 2.2991 2.69 2.95 Part. 2, 9
G-0063 2.2352 1.9420 2.87 2.49 Part. 1
G-0064 2.0312 2.0677 2.63 2.67 Part. 6
POS sensor calibration for all instruments in LAB and for 6 used O2k for the ultramarathon experiments (Exp.).
Sensor calibration was performed in the morning of all 3 days in every instrument and used for each experiment
performed with the same O2k, shown as participants number (Part.). R1: POS-recorded signal [V]. J◦O2 POS: O2
consumption by POS [pmol/s/mL)].
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